131 related articles for article (PubMed ID: 2176130)
1. The role of enoximone in the treatment of cardiogenic shock.
Vincent JL; Léon M; Berré J
Cardiology; 1990; 77 Suppl 3():21-6; discussion 27-33. PubMed ID: 2176130
[TBL] [Abstract][Full Text] [Related]
2. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
[TBL] [Abstract][Full Text] [Related]
3. Administration of enoximone in cardiogenic shock.
Vincent JL; Carlier E; Berré J; Armistead CW; Kahn RJ; Coussaert E; Cantraine F
Am J Cardiol; 1988 Sep; 62(7):419-23. PubMed ID: 2970777
[TBL] [Abstract][Full Text] [Related]
4. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
Schmid ER; Zollinger A; Turina M; Dieterich HA
Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
[TBL] [Abstract][Full Text] [Related]
5. [Use of a new inotropic agent, enoximone, in heart surgery].
Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of verapamil poisoning with noradrenaline and the phosphodiesterase inhibitor enoximone].
Link A; Hammer B; Weisgerber K; Böhm M
Dtsch Med Wochenschr; 2002 Sep; 127(39):2006-8. PubMed ID: 12324881
[TBL] [Abstract][Full Text] [Related]
7. Use of enoximone in weaning from cardiopulmonary bypass following mitral valve surgery.
Tarr TJ; Jeffrey RR; Kent AP; Cowen ME
Cardiology; 1990; 77 Suppl 3():51-7; discussion 62-7. PubMed ID: 2148281
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the effects of enoximone by a dobutamine infusion.
Vincent JL; Madhoun P; Primo G; Kahn RJ
Intensive Care Med; 1989; 15(8):530-1. PubMed ID: 2532656
[TBL] [Abstract][Full Text] [Related]
11. Management of low cardiac output syndrome after cardiac surgery using enoximone.
White DA; Latimer RD; Oduro A
Anaesthesia; 1990 May; 45(5):386-9. PubMed ID: 2141451
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.
Gilbert EM; Hershberger RE; Wiechmann RJ; Movsesian MA; Bristow MR
Chest; 1995 Dec; 108(6):1524-32. PubMed ID: 7497755
[TBL] [Abstract][Full Text] [Related]
13. The effect of enoximone and dobutamine on hemodynamic performance after open heart surgery. A clinical comparison.
Zeplin HE; Dieterich HA; Stegmann T
J Cardiovasc Surg (Torino); 1990; 31(5):574-7. PubMed ID: 2146272
[TBL] [Abstract][Full Text] [Related]
14. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of phosphodiesterase inhibitor enoximone in management of postcardiotomy cardiogenic shock.
Iversen S; Mayer E; Hake U; Schmiedt W; Jakob H; Oelert H
Scand J Thorac Cardiovasc Surg; 1992; 26(2):143-9. PubMed ID: 1439645
[TBL] [Abstract][Full Text] [Related]
16. Addition of enoximone to adrenergic agents in the management of severe heart failure.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567
[TBL] [Abstract][Full Text] [Related]
17. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
Orellano L; Darwisch M; Dieterich HA; Köllner V
Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of enoximone in the management of refractory low-output states following cardiac surgery.
Gonzalez M; Desager JP; Jacquemart JL; Chenu P; Muller T; Installé E
J Cardiothorac Anesth; 1988 Aug; 2(4):409-18. PubMed ID: 17171924
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery.
Tarr TJ; Moore NA; Frazer RS; Shearer ES; Desmond MJ
Eur J Anaesthesiol Suppl; 1993; 8():15-24. PubMed ID: 8223351
[TBL] [Abstract][Full Text] [Related]
20. [Continuous infusion of enoximone in the treatment of acute myocardial ischemia with low output syndrome].
Sicignano A; Bellato V; Riboni A; Vesconi S
Minerva Anestesiol; 1994 Mar; 60(3):109-13. PubMed ID: 8090300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
